Newly-released Pulse Electromagnetic Field Therapy Devices Market industry analysis report by Future Market Insights shows that global sales of the Pulse Electromagnetic Field Therapy Devices Market in 2021 were held at US$ 416.6 million. With 8.6%, the projected market growth from 2022 to 2032 is expected to be higher than the historical growth. The market through the Low-Frequency segment is expected to gross the highest revenue, accounting for a CAGR of nearly 8.8% from 2022 to 2032.
| Attribute | Details |
|---|---|
| Global Pulse Electromagnetic Field Therapy Devices Market (2022) | US$ 452.4 million |
| Global Pulse Electromagnetic Field Therapy Devices Market (2032) | US$ 1 billion |
| Global Pulse Electromagnetic Field Therapy Devices Market CAGR (2022 to 2032) | 8.6% |
| USA Pulse Electromagnetic Field Therapy Devices Market CAGR (2022 to 2032) | 8% |
| Key Companies Profiled |
|
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
As per the Pulse Electromagnetic Field Therapy Devices Market industry research by Future Market Insights - a market research and competitive intelligence provider, historically, from 2017 to 2021, the market value of the Pulse Electromagnetic Field Therapy Devices Market industry increased at around 7.8% CAGR. Countries such as the USA, United Kingdom, China, Japan, and, South Korea held a significant share of the global market.
PEMF (pulsed electromagnetic field) therapy devices are non-invasive and have no known negative effects. PEMF therapy is a treatment option for a variety of musculoskeletal problems. The FDA has approved PEMF devices for the treatment of non-union fractures as well as post-operative osteoarthritis, plantar fasciitis, discomfort, and edema.
These devices also have a number of advantages, including the reduction of chronic and acute pain associated with a variety of connective tissues, such as bone, tendon, ligament, and cartilage injury, as well as the control of edema and inflammation. As a result, the advantages of these devices are expected to drive market expansion.
The market is expected to rise due to an increase in the global elderly population and increased awareness of pulse electromagnetic field (PEMF) therapy devices. The market position is projected to be secured by technological improvements including the development of narrow, downsized PEMF therapeutic devices employing sophisticated materials. The addition of telemedicine is likely to broaden the range of applications for these devices.
Severe spinal injuries, as well as delayed union and non-union fractures, are the most common outcomes of road accidents and trauma, necessitating surgical intervention. During the treatment of failed spinal fusions, delayed unions, fracture non-union, and new fractures, PEMF therapy devices stimulate bone repair.
The International Osteoporosis Foundation estimates that osteoporosis causes 8.9 million fractures per year. Furthermore, approximately 1.6 million hip fractures occur globally each year, with this figure expected to rise to between 4.5 and 6.3 million by 2050. As a result, the demand for PEMF therapy devices is likely to rise as the number of instances of osteoporosis rises.
The surge in the number of fractures due to falls, accidents, and sports injuries and Poor conditions of roads in various countries are some of the factors responsible for the growth of the market. Fractures caused by sports injuries, accidents, falls from a certain height, and symptoms such as arthritis, knee discomfort, and joint pain affect a major section of people around the world.
According to WHO figures, around 1.3 million people die each year as a result of traffic accidents. Furthermore, low- and middle-income countries account for the majority of worldwide traffic fatalities. Poorly maintained roads can result in a variety of injuries and pain in various body areas.
Potholes, uneven roads, broken surfaces, and road cracking can all cause injury to pedestrians, necessitating medical attention. Furthermore, governments' lack of focus on improving road infrastructure raises the risk of accidents and other injuries that can cause significant pain, raising healthcare expenses for individuals.
Interventional Orthopaedics of Atlanta is promoting PEMF therapy, an orthopedic clinic in Atlanta, Georgia, for the treatment of chronic tiredness symptoms, osteoporosis, and poor wound healing. The market for pulse electromagnetic field therapy devices in the United States is growing as a result of these discoveries.
PEMF technology is known for generating energy in the body's cells without requiring invasive surgery. For enterprises in the pulse electromagnetic field (PEMF) therapeutic equipment industry, such advantages translate into value-grab opportunities. PEMF therapy boosts the body's natural function by amplifying the body's natural energy. This therapy aids in the improvement of sports performance as well as the speedier recovery of injuries.
Principal Consultant
Because electromagnetic therapies cause a wide range of interactions within the body, some patients have reported discomfort during their first sessions. As a result, these occurrences occur seldom during the initial stages of treatment. Mild side effects are more common with whole-body treatments and, in rare situations, local therapies.
PEMF side effects are small and transitory, and they normally go away after the therapy is continued. Furthermore, people with electromagnetic hypersensitivity are more likely to have these side effects. Patients may experience overreactions because PEMF therapy has the power to modify biological systems and excite cells or tissues.
United States remains the most dominant country in the Pulse Electromagnetic Field Therapy Market having the expected largest market share of US$ 358.3 million by 2032. The demand for PEMF therapy devices in the United States is expected to rise as the number of individuals suffering from osteoporosis and osteoarthritis rises. Furthermore, the growing shift to minimally invasive procedures is expected to boost regional growth. In addition, the presence of a well-developed healthcare system in the United States is expected to stimulate the demand.
The market in the United Kingdom is projected to reach a valuation of US$ 48 million by 2032. With a CAGR of 9.8% from 2022 to 2032, the market is expected to gross an absolute dollar opportunity of US$ 29 million during the forecast period.
In Japan, the market is expected to reach US$ 46 million by 2032. The market in the country is projected to gross an absolute dollar opportunity of US$ 31 million during the forecast period, growing at a CAGR of 11.6%.
The market in South Korea is projected to witness an absolute dollar opportunity of US$ 9.6 million during the forecast period. By 2032, the market in the country is likely to reach US$ 17 million by 2032, growing at a CAGR of 8.5%.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The Low-Frequency pulsed electromagnetic field therapy devices market is expected to account for the highest CAGR of 8.8%. Low-frequency PEMF devices generate magnetic fields with frequencies that are medium-high but low in intensity. These devices may also be used to address hard tissues and delayed bone growth. Low-frequency PEMF devices are used to treat rheumatoid arthritis inflammation, pain, and impairments in a quick, non-invasive, and simple way. As a result, the use of low-frequency PEMF therapy devices for arthritis treatment is likely to drive growth.
Some of the players operating in the pulse electromagnetic field therapy devices market include Bedfont Scientific, Orthofix Holdings, Nuage Health, Bemer, Oxford Medical Instruments Health, OSKA, Medithera, NiuDeSai, and I-Tech Medical Division.
Some of the recent developments of key players in the Pulse Electromagnetic Field Therapy Devices Market are as follows:
Similarly, recent developments related to companies offering Pulse Electromagnetic Field Therapy Devices Market have been tracked by the team at Future Market Insights, which is available in the full report.
The global Pulse Electromagnetic Field Therapy Devices Market is worth more than US$ 416.6 Million at present.
The value of the Pulse Electromagnetic Field Therapy Devices Market is projected to increase at a CAGR of around 8.6% during 2022 to 2032.
The value of the Pulse Electromagnetic Field Therapy Devices Market increased at a CAGR of around 7.8% from 2017 to 2021.
With a CAGR of 8.3% historically, Low-Frequency segment dominated the Pulse Electromagnetic Field Therapy Devices industry.
The top 5 countries driving demand for Pulse Electromagnetic Field Therapy Devices Market are the USA, the United Kingdom., China, Japan, and South Korea.
The Japanese market for Pulse Electromagnetic Field Therapy Devices is projected to expand at a CAGR of around 11.6% during 2022 to 2032.
While the market in South Korea is expected to grow at nearly 8.5%, the market in the United Kingdom is projected to register a CAGR of nearly 9.8% from 2022 to 2032.
1. Executive Summary| Pulse Electromagnetic Field Therapy Devices Market 1.1. Global Market Outlook 1.2. Summary of Statistics 1.3. Key Market Characteristics & Attributes 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Risks and Trends Assessment 3.1. Risk Assessment 3.1.1. COVID-19 Crisis and Impact on Market 3.1.2. COVID-19 Impact Benchmark with Previous Crisis 3.1.3. Impact on Market Value (US$ million) 3.1.4. Assessment by Key Countries 3.1.5. Assessment by Key Market Segments 3.1.6. Action Points and Recommendation for Suppliers 3.2. Key Trends Impacting the Market 3.3. Formulation and Product Development Trends 4. Market Background 4.1. Market, by Key Countries 4.2. Market Opportunity Assessment (US$ million) 4.2.1. Total Available Market 4.2.2. Serviceable Addressable Market 4.2.3. Serviceable Obtainable Market 4.3. Market Scenario Forecast 4.3.1. Demand in optimistic Scenario 4.3.2. Demand in Likely Scenario 4.3.3. Demand in Conservative Scenario 4.4. Investment Feasibility Analysis 4.4.1. Investment in Established Markets 4.4.1.1. In Short Term 4.4.1.2. In Long Term 4.4.2. Investment in Emerging Markets 4.4.2.1. In Short Term 4.4.2.2. In Long Term 4.5. Forecast Factors - Relevance & Impact 4.5.1. Top Companies Historical Growth 4.5.2. Growth in Automation, By Country 4.5.3. Patch Management Adoption Rate, By Country 4.6. Market Dynamics 4.6.1. Market Driving Factors and Impact Assessment 4.6.2. Prominent Market Challenges and Impact Assessment 4.6.3. Patch Management Market Opportunities 4.6.4. Prominent Trends in the Global Market & Their Impact Assessment 5. Key Success Factors 5.1. Manufacturers’ Focus on Low Penetration High Growth Markets 5.2. Banking on with Segments High Incremental Opportunity 5.3. Peer Benchmarking 6. Global Market Demand Analysis 2017 to 2021 and Forecast, 2022 to 2032 6.1. Historical Market Analysis, 2017 to 2021 6.2. Current and Future Market Projections, 2022 to 2032 6.3. Y-o-Y Growth Trend Analysis 7. Global Market Value Analysis 2017 to 2021 and Forecast, 2022 to 2032 7.1. Historical Market Value (US$ million) Analysis, 2017 to 2021 7.2. Current and Future Market Value (US$ million) Projections, 2022 to 2032 7.2.1. Y-o-Y Growth Trend Analysis 7.2.2. Absolute $ Opportunity Analysis 8. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Component 8.1. Introduction / Key Findings 8.2. Historical Market Size (US$ million) Analysis By Component, 2017 to 2021 8.3. Current and Future Market Size (US$ million) Analysis and Forecast By Component, 2022 to 2032 8.3.1. Low Frequency 8.3.2. High Frequency 8.4. Market Attractiveness Analysis By Component 9. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Application 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ million) Analysis By Application, 2017 to 2021 9.3. Current and Future Market Size (US$ million) Analysis and Forecast By Application, 2022 to 2032 9.3.1. Bone Growth 9.3.2. Pain Management 9.3.3. Other Applications 9.4. Market Attractiveness Analysis By Application 10. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By End-use 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ million) Analysis By End-use, 2017 to 2021 10.3. Current and Future Market Size (US$ million) Analysis and Forecast By End-use, 2022 to 2032 10.3.1. Home Care Settings 10.3.2. Hospitals 10.3.3. Other End-uses 10.4. Market Attractiveness Analysis By End-use 11. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region 11.1. Introduction 11.2. Historical Market Size (US$ million) Analysis By Region, 2017 to 2021 11.3. Current Market Size (US$ million) & Analysis and Forecast By Region, 2022 to 2032 11.3.1. North America 11.3.2. Latin America 11.3.3. Europe 11.3.4. APAC 11.3.5. Middle East and Africa (MEA) 11.4. Market Attractiveness Analysis By Region 12. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032 12.1. Introduction 12.2. Pricing Analysis 12.3. Historical Market Size (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2021 12.4. Market Size (US$ million) & Forecast By Market Taxonomy, 2022 to 2032 12.4.1. By Country 12.4.1.1. The USA 12.4.1.2. Canada 12.4.1.3. Rest of North America 12.4.2. By Component 12.4.3. By End-use 12.4.4. By Application 12.5. Market Attractiveness Analysis 12.5.1. By Country 12.5.2. By Component 12.5.3. By End-use 12.5.4. By Application 13. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032 13.1. Introduction 13.2. Pricing Analysis 13.3. Historical Market Size (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2021 13.4. Market Size (US$ million) & Forecast By Market Taxonomy, 2022 to 2032 13.4.1. By Country 13.4.1.1. Brazil 13.4.1.2. Mexico 13.4.1.3. Rest of Latin America 13.4.2. By Component 13.4.3. By End-use 13.4.4. By Application 13.5. Market Attractiveness Analysis 13.5.1. By Country 13.5.2. By Component 13.5.3. By End-use 13.5.4. By Application 14. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032 14.1. Introduction 14.2. Pricing Analysis 14.3. Historical Market Size (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2021 14.4. Market Size (US$ million) & Forecast By Market Taxonomy, 2022 to 2032 14.4.1. By Country 14.4.1.1. Germany 14.4.1.2. France 14.4.1.3. The United Kingdom 14.4.1.4. Italy 14.4.1.5. Netherlands 14.4.1.6. Belgium 14.4.1.7. Rest of Europe 14.4.2. By Component 14.4.3. By End-use 14.4.4. By Application 14.5. Market Attractiveness Analysis 14.5.1. By Country 14.5.2. By Component 14.5.3. By End-use 14.5.4. By Application 15. APAC Market Analysis 2017 to 2021 and Forecast 2022 to 2032 15.1. Introduction 15.2. Pricing Analysis 15.3. Historical Market Size (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2021 15.4. Market Size (US$ million) & Forecast By Market Taxonomy, 2022 to 2032 15.4.1. By Country 15.4.1.1. China 15.4.1.2. Japan 15.4.1.3. South Korea 15.4.1.4. Rest of APAC 15.4.2. By Component 15.4.3. By End-use 15.4.4. By Application 15.5. Market Attractiveness Analysis 15.5.1. By Country 15.5.2. By Component 15.5.3. By End-use 15.5.4. By Application 16. Middle East and Africa Market Analysis 2017 to 2021 and Forecast 2022 to 2032 16.1. Introduction 16.2. Pricing Analysis 16.3. Historical Market Size (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2021 16.4. Market Size (US$ million) & Forecast By Market Taxonomy, 2022 to 2032 16.4.1. By Country 16.4.1.1. Saudi Arabia 16.4.1.2. South Africa 16.4.1.3. Nigeria 16.4.1.4. Rest of Middle East and Africa 16.4.2. By Component 16.4.3. By End-use 16.4.4. By Application 16.5. Market Attractiveness Analysis 16.5.1. By Country 16.5.2. By Component 16.5.3. By End-use 16.5.4. By Application 17. Key Countries Market Analysis 2017 to 2021 and Forecast 2022 to 2032 17.1. Introduction 17.1.1. Market Value Proportion Analysis, By Key Countries 17.1.2. Global Vs. Country Growth Comparison 17.2. US Market Analysis 17.2.1. Value Proportion Analysis by Market Taxonomy 17.2.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032 17.2.2.1. By Component 17.2.2.2. By End-use 17.2.2.3. By Application 17.3. Canada Market Analysis 17.3.1. Value Proportion Analysis by Market Taxonomy 17.3.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032 17.3.2.1. By Component 17.3.2.2. By End-use 17.3.2.3. By Application 17.4. Mexico Market Analysis 17.4.1. Value Proportion Analysis by Market Taxonomy 17.4.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032 17.4.2.1. By Component 17.4.2.2. By End-use 17.4.2.3. By Application 17.5. Brazil Market Analysis 17.5.1. Value Proportion Analysis by Market Taxonomy 17.5.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032 17.5.2.1. By Component 17.5.2.2. By End-use 17.5.2.3. By Application 17.6. Germany Market Analysis 17.6.1. Value Proportion Analysis by Market Taxonomy 17.6.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032 17.6.2.1. By Component 17.6.2.2. By End-use 17.6.2.3. By Application 17.7. France Market Analysis 17.7.1. Value Proportion Analysis by Market Taxonomy 17.7.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032 17.7.2.1. By Component 17.7.2.2. By End-use 17.7.2.3. By Application 17.8. Italy Market Analysis 17.8.1. Value Proportion Analysis by Market Taxonomy 17.8.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032 17.8.2.1. By Component 17.8.2.2. By End-use 17.8.2.3. By Application 17.9. Netherlands Market Analysis 17.9.1. Value Proportion Analysis by Market Taxonomy 17.9.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032 17.9.2.1. By Component 17.9.2.2. By End-use 17.9.2.3. By Application 17.10. United Kingdom Market Analysis 17.10.1. Value Proportion Analysis by Market Taxonomy 17.10.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032 17.10.2.1. By Component 17.10.2.2. By End-use 17.10.2.3. By Application 17.11. Belgium Market Analysis 17.11.1. Value Proportion Analysis by Market Taxonomy 17.11.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032 17.11.2.1. By Component 17.11.2.2. By End-use 17.11.2.3. By Application 17.12. China Market Analysis 17.12.1. Value Proportion Analysis by Market Taxonomy 17.12.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032 17.12.2.1. By Component 17.12.2.2. By End-use 17.12.2.3. By Application 17.13. Japan Market Analysis 17.13.1. Value Proportion Analysis by Market Taxonomy 17.13.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032 17.13.2.1. By Component 17.13.2.2. By End-use 17.13.2.3. By Application 17.14. South Korea Market Analysis 17.14.1. Value Proportion Analysis by Market Taxonomy 17.14.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032 17.14.2.1. By Component 17.14.2.2. By End-use 17.14.2.3. By Application 17.15. Saudi Arabia Market Analysis 17.15.1. Value Proportion Analysis by Market Taxonomy 17.15.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032 17.15.2.1. By Component 17.15.2.2. By End-use 17.15.2.3. By Application 17.16. South Africa Market Analysis 17.16.1. Value Proportion Analysis by Market Taxonomy 17.16.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032 17.16.2.1. By Component 17.16.2.2. By End-use 17.16.2.3. By Application 17.17. Nigeria Market Analysis 17.17.1. Value Proportion Analysis by Market Taxonomy 17.17.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032 17.17.2.1. By Component 17.17.2.2. By End-use 17.17.2.3. By Application 17.17.3. Competition Landscape and Player Concentration in the Country 18. Market Structure Analysis 18.1. Market Analysis by Tier of Companies 18.2. Market Concentration 18.3. Market Share Analysis of Top Players 18.4. Market Presence Analysis 18.4.1. By Regional footprint of Players 18.4.2. Product footprint by Players 19. Competition Analysis 19.1. Competition Dashboard 19.2. Competition Benchmarking 19.3. Competition Deep Dive 19.3.1. Bedfont Scientific 19.3.1.1. Overview 19.3.1.2. Product Portfolio 19.3.1.3. Sales Footprint 19.3.1.4. Strategy Overview 19.3.2. Orthofix Holdings 19.3.2.1. Overview 19.3.2.2. Product Portfolio 19.3.2.3. Sales Footprint 19.3.2.4. Strategy Overview 19.3.3. Nuage Health 19.3.3.1. Overview 19.3.3.2. Product Portfolio 19.3.3.3. Sales Footprint 19.3.3.4. Strategy Overview 19.3.4. Bemer 19.3.4.1. Overview 19.3.4.2. Product Portfolio 19.3.4.3. Sales Footprint 19.3.4.4. Strategy Overview 19.3.5. Oxford Medical Instruments Health 19.3.5.1. Overview 19.3.5.2. Product Portfolio 19.3.5.3. Sales Footprint 19.3.5.4. Strategy Overview 19.3.6. OSKA 19.3.6.1. Overview 19.3.6.2. Product Portfolio 19.3.6.3. Sales Footprint 19.3.6.4. Strategy Overview 19.3.7. Medithera 19.3.7.1. Overview 19.3.7.2. Product Portfolio 19.3.7.3. Sales Footprint 19.3.7.4. Strategy Overview 19.3.8. NiuDeSai 19.3.8.1. Overview 19.3.8.2. Product Portfolio 19.3.8.3. Sales Footprint 19.3.8.4. Strategy Overview 19.3.9. I-Tech Medical Division 19.3.9.1. Overview 19.3.9.2. Product Portfolio 19.3.9.3. Sales Footprint 19.3.9.4. Strategy Overview 20. Assumptions and Acronyms Used 21. Research Methodology
Explore Healthcare Insights
View Reports
Pulse Electromagnetic Field Therapy Devices Market
